City of Eureka et al v. Purdue Pharma, L.P. et al
City of Eureka and The People of State of California |
McKesson Corporation, Mallinckrodt, LLC, Purdue Pharma, Inc., Allergan PLC, Teva Pharmaceuticals USA, Inc., Endo Pharmaceuticals, Inc., Purdue Pharma, L.P., Actavis LLC, Cardinal Health, Inc., Actavis Pharma, Inc., Watson Laboratories, Inc., Cephalon, Inc., The Purdue Frederick Company, Inc., Endo Health Solutions Inc., Johnson & Johnson, Allergan Finance, LLC, Teva Pharmaceuticals Industries, Ltd., Amerisourcebergen Drug Corporation, Janssen Pharmaceuticals, Inc., Mallinckrodt, PLC, Actavis, Inc., Actavis PLC, Watson Pharmaceuticals, Inc. and Watson Pharma, Inc. |
1:2018cv05353 |
August 30, 2018 |
US District Court for the Northern District of California |
Robert M Illman |
Racketeer/Corrupt Organization |
18 U.S.C. ยง 1961 |
Plaintiff |
Docket Report
This docket was last retrieved on September 24, 2018. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 6 ORDER TRANSFERRING CASE to the Northern District of Ohio. (msrS, COURT STAFF) (Filed on 9/24/2018) |
Remark: Case file electronically transferred to the Northern District of Ohio. (msrS, COURT STAFF) (Filed on 9/24/2018) |
Remark: Case transferred from California Northern has been opened in Northern District of Ohio as case 1:18-op-46092 (msrS, COURT STAFF) (Filed on 9/24/2018) |
Filing 5 Summons Issued as to All Defendants. (msrS, COURT STAFF) (Filed on 8/31/2018) |
Filing 4 Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 11/27/2018. Initial Case Management Conference set for 12/4/2018 02:00 PM in McKinleyville. Parties may participate in the Initial Case Management Conference by telephone and should contact Judge Illman's courtroom deputy for instructions. (msrS, COURT STAFF) (Filed on 8/30/2018) |
Filing 3 Proposed Summons. (Farris, Juli) (Filed on 8/30/2018) |
Filing 2 Case assigned to Magistrate Judge Robert M. Illman. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening.Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 9/13/2018. (bwS, COURT STAFF) (Filed on 8/30/2018) |
Filing 1 COMPLAINT against Actavis LLC, Actavis Pharma, Inc., Allergan Finance, LLC, Allergan PLC, Amerisourcebergen Drug Corporation, Cardinal Health, Inc., Cephalon, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., John and Jane Does 1 through 100, Johnson & Johnson, Mallinckrodt, LLC, Mallinckrodt, PLC, McKesson Corporation, Purdue Pharma, Inc., Purdue Pharma, L.P., Teva Pharmaceuticals Industries, Ltd., Teva Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc. ( Filing fee $ 400, receipt number 0971-12641365.). Filed byThe People of State of California, City of Eureka. (Attachments: #1 Civil Cover Sheet, #2 Summons)(Farris, Juli) (Filed on 8/30/2018) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.